GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Insider Ownership

Smith & Nephew (Smith & Nephew) Insider Ownership : 0.30 % (As of Apr. 27, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Smith & Nephew's insider ownership is 0.30%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Smith & Nephew's Institutional Ownership is 2.15%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Smith & Nephew's Float Percentage Of Total Shares Outstanding is 0.00%.


Smith & Nephew Insider Ownership Historical Data

The historical data trend for Smith & Nephew's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Insider Ownership Chart

Smith & Nephew Historical Data

The historical data trend for Smith & Nephew can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Insider Ownership 0.29 0.29 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30

Smith & Nephew Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Smith & Nephew (Smith & Nephew) Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus